Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

The startup’s first prospect is a heart medicine that works differently than the hypertrophic cardiomyopathy drugs developed ...

Already facing headwinds caused by a patient’s death and treatment delays, the biotech now may have to contend with a less ...

Siren Biotechnology is trying to raise $5 million via the type of crowdfunding round that’s rarely used by young drugmakers.

A version of meloxicam designed to work faster has beat out a placebo in two late-stage studies focused on post-surgical ...

Vor Bio, Korro Bio, Insitro and Rallybio revealed plans to lay off chunks of their respective workforces in the latest job ...

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

Sales of the company’s copycat to J&J’s blockbuster reached $150 million in the first quarter, adding to a surge in revenue ...

While updated study results confirmed the drug lowers a target protein, the therapy's effect on clinical outcomes was less ...

Experts say market turmoil has made it harder for buyers and sellers to agree on price, which can be an especially imposing ...

A vocal opponent of his predecessor Peter Marks, Vinay Prasad will now lead the office tasked with reviewing some genetic ...